BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 17414213)

  • 21. Fibrin(ogen) and thrombotic disease.
    Ariëns RA
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():294-305. PubMed ID: 23809133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of carboxypeptidase N to fibrinogen and fibrin.
    Talens S; Lebbink JH; Malfliet JJ; Demmers JA; Uitte de Willige S; Leebeek FW; Rijken DC
    Biochem Biophys Res Commun; 2012 Oct; 427(2):421-5. PubMed ID: 23000409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heritability of clot formation.
    Standeven KF; Uitte de Willige S; Carter AM; Grant PJ
    Semin Thromb Hemost; 2009 Jul; 35(5):458-67. PubMed ID: 19739036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemostatic factors and coronary heart disease.
    Pilgeram LO
    Biomed Pharmacother; 1982; 36(4):187-9. PubMed ID: 7165789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple interactions of FbsA, a surface protein from Streptococcus agalactiae, with fibrinogen: affinity, stoichiometry, and structural characterization.
    Pietrocola G; Visai L; Valtulina V; Vignati E; Rindi S; Arciola CR; Piazza R; Speziale P
    Biochemistry; 2006 Oct; 45(42):12840-52. PubMed ID: 17042502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin polymerization and its regulatory role in hemostasis.
    Mosesson MW
    J Lab Clin Med; 1990 Jul; 116(1):8-17. PubMed ID: 2198321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structure.
    Carr ME; Gabriel DA; Herion JC; Roberts HR
    J Lab Clin Med; 1986 Mar; 107(3):199-203. PubMed ID: 3950465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen and fibrin clot structure in diabetes.
    Dunn EJ; Ariëns RA
    Herz; 2004 Aug; 29(5):470-9. PubMed ID: 15340732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
    Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
    Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen structure and fibrin clot assembly.
    Mosesson MW
    Semin Thromb Hemost; 1998; 24(2):169-74. PubMed ID: 9579639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of a 34-kDa, heat stable glycoprotein from Synadenium grantii latex: action on human fibrinogen and fibrin clot.
    Rajesh R; Nataraju A; Gowda CD; Frey BM; Frey FJ; Vishwanath BS
    Biochimie; 2006 Oct; 88(10):1313-22. PubMed ID: 16997451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F; Kani S; Hongo M; Okumura N
    Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrin precursors, intermediaries for hemostasis in the clot war.
    Shainoff JR; DiBello PM
    Thromb Res; 2002 Jan; 105(1):3-13. PubMed ID: 11864700
    [No Abstract]   [Full Text] [Related]  

  • 36. Determinants of fibrin formation, structure, and function.
    Wolberg AS
    Curr Opin Hematol; 2012 Sep; 19(5):349-56. PubMed ID: 22759629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function: its clinical significance.
    Ginsburg AD; Aster RH
    Dis Mon; 1970 Sep; ():2-42. PubMed ID: 4918554
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clot.
    Rijken DC; Dirkx SP; Luider TM; Leebeek FW
    Biochem Biophys Res Commun; 2006 Nov; 350(1):191-4. PubMed ID: 16996032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen and fibrin.
    Weisel JW
    Adv Protein Chem; 2005; 70():247-99. PubMed ID: 15837518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The roles of fibrinogen and fibrin in hemostasis and thrombosis.
    Mosesson MW
    Semin Hematol; 1992 Jul; 29(3):177-88. PubMed ID: 1641664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.